Erratum: Etomidate infusion at low doses is an effective and safe treatment for severe Cushing’s syndrome outside intensive care (European Journal of Endocrinology 183:2 (161-167) DOI: 10.1530/EJE-20-0380)

Constantinescu, Stefan;Driessens, Natacha;Lefebvre, Aurélie;Furnica, Raluca-Maria;Maiter, Dominique;et.al.
(2020) European Journal of Endocrinology — Vol. 183, n° 6, p. X7 (2020)

Files

2020_Constantinescu_Eur_J_Endocrinol_erratum.pdf
  • Open Access
  • Adobe PDF
  • 88.9 KB
Download

Details

Authors
Show more
Abstract
The authors of the aforementioned article published in this journal (vol 183 Iss 2 pages: 161–167) apologise for errors in reporting the dosage of etomidate in several places in their article. [...]
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Constantinescu, S., Driessens, N., Lefebvre, A., Furnica, R.-M., Corvilain, B., & Maiter, D. (2020). Erratum: Etomidate infusion at low doses is an effective and safe treatment for severe Cushing’s syndrome outside intensive care (European Journal of Endocrinology 183:2 (161-167) DOI: 10.1530/EJE-20-0380). European Journal of Endocrinology, 183(6), X7. https://doi.org/10.1530/eje-20-0380e (Original work published 2020)